HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
NCT06236269
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Stage IV
Interventions
DRUG:
Sacituzumab Govitecan
Sponsor
SOLTI Breast Cancer Research Group